Skip to content

The return of treatment interruptions?

If you can't switch, better to stay on failing treatment than stop it, studies show

Treatment breaks set for a come-back?

Continued antiretroviral therapy reduces bone mineral density in SMART study

BHIVA: Many patients and clinicians still need educating about the benefits of treatment

Planned interruption of highly active antiretroviral therapy does not select drug resistance mutations in HIV-1-infected children

Benefit of starting HIV treatment early outweighs the risk of toxicities, SMART study shows

SMART study reaffirms that HIV replication is harmful, even at CD4 counts above 350

CROI: Biomarker changes may help explain detrimental effects of treatment interruption